DAFTAR REFERENSI

1. Heng A-E, Cano NJM. Nutritional problems in adult patients with stage 5
chronic kidney disease on dialysis (both haemodialysis and peritoneal
dialysis). NDT Plus. 2010;3:109–17.

2. Global Facts: About Kidney Disease [Internet]. The National Kidney

Foundation. 2015 [cited 2017 Aug 22]. Available from:
https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease

3. Departemen Kesehatan Republik Indonesia. Riset Kesehatan Dasar

(RISKESDAS) 2013. Badan Penelitian dan Pengembangan Kesehatan;
2013.

4. Perkumpulan Nefrologi Indonesia (Pernefri). 4th Report of Indonesian

Renal Registry [Internet]. Indonesia Renal Registry; 2014 [cited 2017 Aug
22]. Available from: http://www.indonesianrenalregistry.org/data/5th%
20Annual%20Report%20Of%20IRR%202012.pdf

5. Kalantar-Zadeh K, Kopple JD. Nutritional Management of Maintenance

Hemodialysis Patients. In: Kopple JD, Massry SG, Kalantar-Zadeh K,
editors. Nutritional management of renal disease. Third edition.
Amsterdam: Elsevier/AP; 2013. p. 503–38.

6. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse

epidemiology of cardiovascular risk factors in maintenance dialysis
patients. Kidney Int. 2003;63:793–808.

7. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height

relationships predict mortality in maintenance hemodialysis patients.
Kidney Int. 1999;56:1136–48.

8. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger

SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of
incident hypertension. Hypertension. 2007 May;49(5):1063–9.

9. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson

JE, et al. Vitamin D and calcium intake in relation to type 2 diabetes in
women. Diabetes Care. 2006 Mar;29(3):650–6.

10. National Kidney Foundation. KDOQI Clinical Practice Guidelines for

Nutrition in Chronic Renal Failure. National Kidney Foundation [Internet].
2000 [cited 2017 Aug 22]; Available from:
http://www2.kidney.org/professionals/kdoqi/guidelines_nutrition/nut_a12.
html#
11. Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D, Levin A, et al.
KDIGO 2012 Clinical practice guideline for the evaluation and
management of chronic kidney disease. Kidney Int. 2013;3:5–14.

12. Cruz MC, Andrade C, Urrutia M, Draibe S, Nogueira-Martins LA, de

Castro Cintra Sesso R. Quality of life in patients with chronic kidney
disease. Clinics. 2011;66:991–5.

13. Sherwood L. The Urinary System. In: Human physiology: from cells to
systems. 9th edition. Boston, MA, USA: Cengage Learning; 2016. p. 491–
534.

14. Despopoulos A, Silbernagl S. Kidneys, Salt, and Water Balance. In: Color
atlas of physiology. 5. ed., compl. rev. and expanded. Stuttgart: Thieme;
2003. p. 148–85. (Thieme Flexibook).

15. Tortora GJ, Derrickson B. Principles of anatomy & physiology. 13th ed.
New Jersey: John Wiley & Sons, Inc.; 2012.

16. Tortora GJ, Derrickson B. Principles of anatomy and physiology. Danvers:

John Wiley & Sons, Inc.; 2012.

17. Sherwood, L. Human Physiology: From Cells to Systems. 7th ed. Belmont:
Cole Cengange Learning; 2013.

18. National Kidney Foundation. KDOQI Clinical practice guidelines and

clinical practice recommendations for diabetes and chronic kidney disease.
Am J Kidney Dis. 2007;49:S1–180.

19. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications
and implications. American Journal of Kidney Diseases. 2009;53:S4–16.

20. National Kidney Foundation. Clinical practice guidelines for chronic

kidney disease: evaluation, classification and stratification. New York:
National Kidney Foundation; 2002.

21. Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney
Int Suppl. 2013;3:368–71.

22. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic

kidney disease: global dimension and perspectives. The Lancet.
2013;382:260–72.

23. Prodjosudjadi W, Suwitra K, Widiana IGR, Loekman JS, Nainggolan G,

Prasanto H, et al. Detection and prevention of chronic kidney disease in
Indonesia: initial community screening. Nephrology. 2009;14:669–74.
24. Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P,
Kiattisunthorn K, et al. Prevalence and risk factors of chronic kidney
disease in the Thai adult population: Thai SEEK study. Nephrology
Dialysis Transplantation. 2010;25:1567–75.

25. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention
of chronic kidney disease. The Lancet. 2010;375:1296–309.

26. Silbernagl S, Lang F. Kidney, Salt, and Water Balance. In: Color atlas of
pathophysiology. Stuttgart ; New York: Thieme; 2000. p. 92–133.

27. López-Novoa JM, Martínez-Salgado C, Rodríguez-Peña AB, Hernández

FJL. Common pathophysiological mechanisms of chronic kidney disease:
Therapeutic perspectives. Pharmacology & Therapeutics. 2010;128:61–
81.

28. Kasper DL, editor. Chronic Kidney Disease. In: Harrison’s principles of
internal medicine. 19th edition. New York: McGraw Hill Education; 2015.
p. 1811–21.

29. Cheung BMY, Li C. Diabetes and Hypertension: Is There a Common

Metabolic Pathway? Current Atherosclerosis Reports. 2012;14:160–6.

30. Stas SN, El-Atat FA, Sowers JR. Pathogenesis of Hypertension in

Diabetes. Rev Endocr Metab Disord. 2004;5:221–5.

31. U.S Renal Data System. Annual data report: atlas of end-stage renal
disease in the United States. Bethesda; 2009.

32. Levey AS, Coresh J. Chronic kidney disease. The Lancet. 2012;379:165–
80.

33. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, De Boer IH, Goldstein-
Fuchs J, et al. Diabetic kidney disease: a report from an ADA Consensus
Conference. Am J Kidney Dis. 2014;64:510–33.

34. Reidy K, Kang HM, Hostetter T, Susztak K. Molecular mechanisms of

diabetic kidney disease. The Journal of clinical investigation.
2014;124:2333–40.

35. Kanwar YS, Sun L, Xie P, Liu F, Chen S. A glimpse of various

pathogenetic mechanisms of diabetic nephropathy. Ann Rev Pathol.
2011;6:395–423.

36. Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A. The association

between congestive heart failure and chronic renal disease. Curr Opin
Nephrol Hypertens. 2004;13:163–70.
37. Geisberg C, Butler J. Addressing the challenges of cardiorenal syndrome.
Cleve Clin J Med. 2006;73:485–91.

38. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe
cardiorenal syndrome: “Guyton revisited.” Eur Heart J. 2005;26:11–7.

39. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL,
et al. Kidney disease as a risk factor for development of cardiovascular
disease: a statement from the American Heart Association Councils on
Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical
Cardiology, and Epidemiology and Prevention. Hypertension.
2003;42:1050–65.

40. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal

Syndrome. Journal of the American College of Cardiology. 2008;52:1527–
39.

41. Francis G. Acute decompensated heart failure: the cardiorenal syndrome.

Cleve Clin J Med. 2006;73:S8–13.

42. Davenport A, Anker SD, Mebazaa A, Palazzuoli A, Vescovo G, Bellomo

R, et al. ADQI 7: the clinical management of the Cardio-Renal syndromes:
work group statements from the 7th ADQI consensus conference.
Nephrology Dialysis Transplantation. 2010;25:2077–89.

43. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw

SM, et al. Cardio-renal syndromes: report from the consensus conference
of the Acute Dialysis Quality Initiative. Eur Heart J. 2010;31:703–11.

44. Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR,
Abraham WT, et al. Characteristics and outcomes of patients hospitalized
for heart failure in the United States: rationale, design, and preliminary
observations from the first 100,000 cases in the Acute Decompensated
Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–
16.

45. Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated
heart failure and the cardiorenal syndrome. Crit Care Med. 2008;36:S75–
88.

46. Amann K, Tyralla K. Cardiovascular changes in chronic renal failure--

pathogenesis and therapy. Clin Nephrol. 2002;58:S62–72.

47. Bargman J, Skorecki K. Chronic kidney disease. In: Kasper DL, Fauci AS,
Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison’s Principles
of Internal Medicine. 19th edition. New York: McGraw-Hill Education;
2015. p. 1810–1.
48. Nahikian-Nelms M, editor. Diseases of the Renal System. In: Nutrition
therapy and pathophysiology. 2nd ed. Belmont, CA: Wadsworth, Cengage
Learning; 2011. p. 520–61.

49. Babitt JL, Lin HY. Mechanisms of anemia in CKD. Journal of the
American Society of Nephrology. 2012;23:1631–4.

50. Kopple JD. Nutrition, diet, and the kidney. In: Ross AC, Caballero B,
Cousins RJ, Tucker KL, Ziegler TR, editors. Modern Nutrition in Health
and Disease. 11th edition. Philadelphia: LWW; 2012. p. 1330–64.

51. Silbernagl S, Lang F. Chronic Renal Failure: Abnormal Regulation. In:

Color atlas of pathophysiology. Stuttgart ; New York: Thieme; 2000. p. 92–
133.

52. Zha Y, Qian Q. Protein nutrition and malnutrition in CKD and ESRD.
Nutrients. 2017;9:1–19.

53. Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney
disease. Nature reviews Nephrology. 2014;10:504–16.

54. Moe SM, Drüeke T, Lameire N, Eknoyan G. Chronic kidney disease–

mineral-bone disorder: a new paradigm. Advances in chronic kidney
disease. 2007;14:3–12.

55. Parmar JA, Sagar AR, Kapadia S, Joshi A, Chakrabarti M. A study of

parathyroid hormone, total calcium, creatinine and urea in chronic kidney
disease. Int J Res Med. 2015;6:47–9.

56. Gropper SS, Smith JL. Advanced Nutrition and Human Metabolism. 6th
edition. Belmont: Wadsworth Publishing; 2012. 608 p.

57. Spiegel DM, Brady K. Calcium balance in normal individuals and in

patients with chronic kidney disease on low-and high-calcium diets.
Kidney international. 2012;81:1116–22.

58. Cibulka R, Racek J. Metabolic complications of chronic kidney failure and

hemodialysis. Special problems in hemodialysis patients Croatia: InTech.
2011;155–66.

59. Langman CB, Cannata-Andía JB. Calcium in chronic kidney disease:

myths and realities. Clinical Journal of the American Society of
Nephrology. 2010;5:S1–2.

60. Canada T, Tajchman S, Ybarra J, editors. A.S.P.E.N Fluids, Electrolytes,

and Acid-Base Disorders Handbook. American Society for Parenteral and
Enteral Nutrition; 2015.
61. Obrador GT, Pereira BJG. Systemic complications of chronic kidney
disease. Pinpointing clinical manifestations and best management.
Postgrad Med. 2002;111:115–22.

62. Lankhorst CE, Wish JB. Anemia in renal disease: diagnosis and
management. Blood Rev. 2010;24:39–47.

63. Urrechaga E, Borque L, F. J. Assessing Iron Status in CKD Patients: New

Laboratory Parameters. In: Gz M, editor. Chronic Kidney Disease
[Internet]. InTech; 2012 [cited 2017 Dec 5]. Available from:
http://www.intechopen.com/books/chronic-kidney-disease/assessing-iron-
status-in-ckd-patients-new-laboratory-parameters

64. Zhao N, Zhang A-S, Enns CA. Iron regulation by hepcidin. J Clin Invest.
2013;123:2337–43.

65. Gaweda AE. Markers of iron status in chronic kidney disease. Hemodial
Int. 2017;21:S21–7.

66. Brugnara C, Schiller B, Moran J. Reticulocyte hemoglobin equivalent (Ret

He) and assessment of iron-deficient states. Clin Lab Haematol.
2006;28:303–8.

67. Eguchi A, Tsuchiya K, Tsukada M, Nitta K. Clinical usefulness of

reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-
dialysis stage and in patients on peritoneal dialysis. Nihon Jinzo Gakkai
Shi. 2010;52:132–40.

68. Garzia M, Di Mario A, Ferraro E, Tazza L, Rossi E, Luciani G, et al.

Reticulocyte hemoglobin equivalent: an indicator of reduced iron
availability in chronic kidney diseases during erythropoietin therapy. Lab
Hematol. 2007;13:6–11.

69. Eschbach, JW, Downing, MR, Egrie, JC, Browne, JK, Adamson, JW. USA
multicenter clinical trial with recombinant human erythropoietin.
Contributions to Nephrology. 1989;76:160–5.

70. Macdougall, IC. Poor response to EPO: practical guidelines on

investigation and management. Nephrology Dialysis Transplantation.
1995;10:607–14.

71. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen

G, et al. Etiology of the protein-energy wasting syndrome in chronic
kidney disease: a consensus statement from the International Society of
Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23:77–90.

72. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L,

et al. A proposed nomenclature and diagnostic criteria for protein–energy
 wasting in acute and chronic kidney disease. Kidney International.
2008;73:391–8.

73. Kopple JD, Massry SG, Kalantar-Zadeh K, editors. Carbohydrate

Metabolism in Kidney Disease and Kidney Failure. In: Nutritional
management of renal disease. Third edition. Amsterdam: Elsevier/AP;
2013. p. 17–30.

74. Kopple JD, Massry SG, Kalantar-Zadeh K, editors. The Influence of

Kidney Disease on Protein and Amino Acid Metabolism. In: Nutritional
management of renal disease. Third edition. Amsterdam: Elsevier/AP;
2013. p. 1–16.

75. Kopple JD, Massry SG, Kalantar-Zadeh K, editors. Altered Lipid

Metabolism and Serum Lipids in Kidney Disease and Kidney Failure. In:
Nutritional management of renal disease. Third edition. Amsterdam:
Elsevier/AP; 2013. p. 31–48.

76. Rhoades R, Pflanzer RG. Human physiology. Australia; Pacific Grove,

Calif.: Thomson : Brooks/Cole; 2003.

77. Güneş FE. Medical nutrition therapy for hemodialysis patients. In: Suzuki
H, editor. Hemodialysis. Lancashire: InTech; 2013. p. 21–43.

78. Wilkens K, Juneja V, Shanaman E. Medical nutrition therapy for renal

disorders. In: Mahan LK, Raymond JL, Escott-Stump S, editors. Krause’s
Food & the Nutrition Care Process. 13th edition. St. Louis: Saunders;
2011. p. 799–831.

79. Kreymann KG, Berger MM, Deutz NEP, Hiesmayr M, Jolliet P,

Kazandjiev G, et al. ESPEN Guidelines on Enteral Nutrition: Intensive
care. Clin Nutr. 2006;25:210–23.

80. Ikizler TA. Dietary protein restriction in CKD: the debate continues. Am J
Kidney Dis. 2009;53:189–91.

81. Kasiske B, Cosio FG, Beto J, Chavers B, Grimm R, Levin A, et al.

KDOQI Clinical practice guidelines for managing dyslipidemias in chronic
kidney disease. American Journal of Kidney Diseases. 2003;41.

82. Oh S, Kalyani RR, Dobs A. Nutritional management of diabetes mellitus.

In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors.
Modern Nutrition in Health and Disease. Eleventh edition. Philadelphia:
LWW; 2012.

83. National Cholesterol Education Program (NCEP) Expert Panel. Detection,

evaluation, and treatment of high blood cholesterol in adults (Adult
Treatment Panel III) final report. Circulation. 2002;106:3143–3143.
84. Franz M. Medical nutrition therapy for diabetes mellitus and
hypoglycemia of nondiabetic origin. In: Mahan LK, Raymond JL, Escott-
Stump S, editors. Krause’s Food & the Nutrition Care Process. 13th
edition. St. Louis: Saunders; 2011.

85. Dworatzek PD, Arcudi K, Gougeon R, Husein N, Sievenpiper JL,

Williams SL. Nutrition therapy. Canadian Journal of Diabetes. 2013
Apr;37:S45–55.

86. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis
EJ, et al. Nutrition therapy recommendations for the management of adults
with diabetes. Diabetes Care. 2013;36:3821–42.

87. Heimburger DC. Ilness-associated malnutrition. In: Sobotka L, editor.

Basics in Clinical Nutrition. 4th ed. Czech: Publishing House Galen; 2011.

88. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Hypothesis: fructose-
induced hyperuricemia as a causal mechanism for the epidemic of the
metabolic syndrome. Nat Clin Pract Nephrol. 2005;1:80–6.

89. Farhadnejad H, Asghari G, Mirmiran P, Yuzbashian E, Azizi F.

Micronutrient intakes and incidence of chronic kidney disease in adults:
Tehran Lipid and Glucose Study. Nutrients. 2016;8:217.

90. Kandula P, Dobre M, Schold JD, Schreiber MJ, Mehrotra R, Navaneethan

SD. Vitamin D supplementation in chronic kidney disease: a systematic
review and meta-analysis of observational studies and randomized
controlled trials. Clinical Journal of the American Society of Nephrology.
2011;6:50–62.

91. Departemen Kesehatan RI. Angka Kecukupan Gizi (AKG) 2013.

Departemen Kesehatan; 2013.

92. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, et al. A
bimodal association of vitamin D levels and vascular disease in children
on dialysis. Journal of the American Society of Nephrology.
2008;19:1239–46.

93. Zhang D, Li H, Yin D, Wang L, Ma Y. Ergocalciferol versus calcitriol for

controlling chronic kidney disease mineral bone disorder in stage 3 to 5
CKD: A randomized controlled trial. European journal of pharmacology.
2016;789:127–33.

94. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al.
Vitamin D2 is as effective as vitamin D3 in maintaining circulating
concentrations of 25-hydroxyvitamin D. The Journal of Clinical
Endocrinology & Metabolism. 2008;93:677–81.
95. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than
vitamin D3 in humans. The Journal of Clinical Endocrinology &
Metabolism. 2004;89:5387–91.

96. Bolton K, Coburn J, Chertow G. KDOQI Clinical practice guidelines for

bone metabolism and disease in chronic kidney disease. National Kidney
Foundation-Kidney Disease Outcomes Quality Initiative (K/DOQI). 2002.

97. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work

Group. KDIGO clinical practice guideline for the diagnosis, evaluation,
prevention, and treatment of Chronic Kidney Disease-Mineral and Bone
Disorder (CKD-MBD). Kidney international Supplement. 2009:S1.

98. Voinescu A, Martin KJ. Calcium, Phosphate, PTH, Vitamin D, and FGF-23
in Chronic Kidney Disease. In: Kopple JD, Massry SG, Kalantar-Zadeh K,
editors. Nutritional management of renal disease. Third edition.
Amsterdam: Elsevier/AP; 2013. p. 263–84.

99. Heidelbaugh JJ. Proton pump inhibitors and risks of mineral deficiency:
evidence and clinical implications. Therapeutic Advances in Drug Safety.
2013.

100. Katzung B, Trevor A. Basic and Clinical Pharmacology. 13th edition.

USA: McGraw-Hill Education; 2014. 1216.

101. Lee P, Kengne A, Greenfield J, Day R, Chalmers J, Ho K. Metabolic

sequelae of β-blocker therapy: weighing in on the obesity epidemic?
International journal of obesity. 2011;35:1395–403.

102. Deichmann R, Lavie C, Andrews S. Coenzyme q10 and statin-induced

mitochondrial dysfunction. The ochsner journal. 2010;10:16–21.

103. Santos ACB dos, Machado M do C, Pereira LR, Abreu JLP, Lyra MB.
Association between the level of quality of life and nutritional status in
patients undergoing chronic renal hemodialysis. Jornal Brasileiro de
Nefrologia. 2013;35:279–88.

104. Zhang Y, QU B, Lun S, Guo Y, Liu J. The 36-Item Short Form Health
Survey: Reliability and Validity in Chinese Medical Students. Int J Med
Sci. 2012;9:521–6.

105. Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR.
Chronic kidney disease and life expectancy. Nephrol Dial Transplant.
2012;27:3182–6.
106. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure:
a meta-analysis of randomized trials. Implications for public health. J Hum
Hypertens. 2002;16:761–70.

107. Larsson SC, Wallin A, Wolk A. Dietary Approaches to Stop Hypertension

Diet and Incidence of Stroke: Results From 2 Prospective Cohorts. Stroke.
2016;47:986–90.

108. Kalaitzidis RG, Karasavvidou D, Siamopoulos KC. Hypertension and

Chronic Kidney Disease: Pathophysiology and Management Strategies.
BANTAO Journal. 2011;49–58.

109. Gunal AI. How to determine “dry weight”? Kidney Int Suppl (2011).
2013;3:377–9.

110. Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, et al.

Advanced glycation end products in foods and a practical guide to their
reduction in the diet. J Am Diet Assoc. 2010;110:911–6.e12.

111. Yacoub R, Habib H, Lahdo A, Al Ali R, Varjabedian L, Atalla G, et al.

Association between smoking and chronic kidney disease: a case control
study. BMC Public Health. 2010;10:731.

112. Luevano-Contreras C, Chapman-Novakofski K. Dietary Advanced

Glycation End Products and Aging. Nutrients. 2010;2:1247–65.

113. Asghari G, Yuzbashian E, Shahemi S, Gaeini Z, Mirmiran P, Azizi F.

Dietary total antioxidant capacity and incidence of chronic kidney disease
in subjects with dysglycemia: Tehran Lipid and Glucose Study. Eur J Nutr.
2017.

114. Chang A, Kramer H. Effect of Obesity and the Metabolic Syndrome on

Incident Kidney Disease and the Progression to Chronic Kidney Failure.
In: Nutritional Management of Renal Disease [Internet]. Elsevier; 2013
[cited 2017 Nov 9]. p. 445–56. Available from:
http://linkinghub.elsevier.com/retrieve/pii/B978012391934200028X

115. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O.

Obesity and Risk for Chronic Renal Failure. JASN. 2006;17:1695–702.

116. Williams ME, Magerowski G, Blackburn GL. Nutritional and Metabolic

Management of Obesity and the Metabolic Syndrome in the Patient with
Chronic Kidney Disease. In: Nutritional Management of Renal Disease
[Internet]. Elsevier; 2013 [cited 2017 Nov 9]. p. 457–71. Available from:
http://linkinghub.elsevier.com/retrieve/pii/B9780123919342000291

117. Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang S-
HS, et al. Association between Water Intake, Chronic Kidney Disease, and
 Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data.
American Journal of Nephrology. 2013;37:434–42.

118. Herber-Gast G-CM, Essen H van, Verschuren WM, Stehouwer CD,

Gansevoort RT, Bakker SJ, et al. Coffee and tea consumption in relation to
estimated glomerular filtration rate: results from the population-based
longitudinal Doetinchem Cohort Study. Am J Clin Nutr. 2016;ajcn112755.

119. Bigotte Vieira M, Magriço R, Viegas dias C, Leitão L, Neves, JS. Caffeine
consumption may help kidney disease patients live longer [Internet].
American Society of Nephrology; 2017. Available from: https://www.asn-
online.org/education/kidneyweek/2017/program-abstract.aspx?
controlId=2784081

120. Bolignano D, Coppolino G, Barillà A, Campo S, Criseo M, Tripodo D, et

al. Caffeine and the kidney: what evidence right now? J Ren Nutr.
2007;17:225–34.

121. Steiber A l. Herbal Supplements in Patients with Kidney Disease. In:

Nutritional Management of Renal Disease [Internet]. Elsevier; 2013 [cited
2017 Dec 10]. p. 711–27. Available from:
http://linkinghub.elsevier.com/retrieve/pii/B9780123919342000436

122. Prakash S, Hernandez GT, Dujaili I, Bhalla V. Lead poisoning from an

Ayurvedic herbal medicine in a patient with chronic kidney disease. Nat
Rev Nephrol. 2009;5:297–300.

123. Hirschberg R. Drug–Nutrient Interactions in Renal Failure. In: Nutritional

Management of Renal Disease [Internet]. Elsevier; 2013 [cited 2017 Nov
10]. p. 729–38. Available from:
http://linkinghub.elsevier.com/retrieve/pii/B9780123919342000448

124. Kopple JD, Massry SG, Kalantar-Zadeh K, editors. Causes of Protein-

Energy Wasting in Chronic Kidney Disease. In: Nutritional management of
renal disease. Third edition. Amsterdam: Elsevier/AP; 2013. p. 159–70.

125. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous
dietary protein intake during progression of chronic renal failure. J Am Soc
Nephrol. 1995;6:1386–91.

126. Lee SW, Song JH, Kim GA, Yang HJ, Lee KJ, Kim MJ. Effect of dialysis
modalities on gastric myoelectrical activity in end-stage renal disease
patients. Am J Kidney Dis. 2000;36:566–73.

127. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, et al.
Inflammatory signals associated with hemodialysis. Kidney Int.
2002;62:1408–16.
128. Brymora A, Flisiński M, Johnson RJ, Goszka G, Stefańska A, Manitius J.
Low-fructose diet lowers blood pressure and inflammation in patients with
chronic kidney disease. Nephrol Dial Transplant. 2012;27:608–12.

129. Chmielewski M, Heimbürger O, Stenvinkel P, Lindholm B. Uremic

Toxicity. In: Nutritional Management of Renal Disease [Internet]. Elsevier;
2013 [cited 2017 Nov 10]. p. 49–77. Available from:
http://linkinghub.elsevier.com/retrieve/pii/B9780123919342000047

130. Mehrotra R, Zhang M, Li Y. Nutrition and Anemia in End-stage Renal

Disease. In: Nutritional Management of Renal Disease [Internet]. Elsevier;
2013 [cited 2017 Nov 10]. p. 383–91. Available from:
http://linkinghub.elsevier.com/retrieve/pii/B9780123919342000254

131. Svensson M, Schmidt EB, Jørgensen KA, Christensen JH. The effect of n-
3 fatty acids on lipids and lipoproteins in patients treated with chronic
haemodialysis: a randomized placebo-controlled intervention study.
Nephrol Dial Transplant. 2008;23:2918–24.